Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Sertraline-induced hypersensitivity pneumonitis

View through CrossRef
Hypersensitivity pneumonitis (HP), also known as extrinsic allergic alveolitis, is a granulomatous, non-IgE-mediated hypersensitivity reaction of the alveoli and distal bronchioles presenting as an acute, subacute or chronic condition. It is most commonly associated with exposure to extrinsic allergens (eg, avian dust, mould and tobacco) and medications including antiarrhythmics (eg, amiodarone), cytotoxics (eg, methotrexate) and antiepileptics (eg, carbamazepine). Individuals diagnosed with this condition can present with severe hypoxia and respiratory failure. The fundamental principle of management is to remove the causative allergen. Evidence implicating selective serotonin reuptake inhibitors as a causative agent is limited, and this case report describes a rare clinical presentation of HP associated with sertraline, how it was diagnosed and subsequently treated. It is anticipated that raising awareness of this interaction will assist multidisciplinary teams, managing patients diagnosed with HP, to be more cognisant of sertraline as being an aetiological factor for this condition.
Title: Sertraline-induced hypersensitivity pneumonitis
Description:
Hypersensitivity pneumonitis (HP), also known as extrinsic allergic alveolitis, is a granulomatous, non-IgE-mediated hypersensitivity reaction of the alveoli and distal bronchioles presenting as an acute, subacute or chronic condition.
It is most commonly associated with exposure to extrinsic allergens (eg, avian dust, mould and tobacco) and medications including antiarrhythmics (eg, amiodarone), cytotoxics (eg, methotrexate) and antiepileptics (eg, carbamazepine).
Individuals diagnosed with this condition can present with severe hypoxia and respiratory failure.
The fundamental principle of management is to remove the causative allergen.
Evidence implicating selective serotonin reuptake inhibitors as a causative agent is limited, and this case report describes a rare clinical presentation of HP associated with sertraline, how it was diagnosed and subsequently treated.
It is anticipated that raising awareness of this interaction will assist multidisciplinary teams, managing patients diagnosed with HP, to be more cognisant of sertraline as being an aetiological factor for this condition.

Related Results

ILP4 and InR regulate Paclitaxel-induced hypersensitivity differently in Drosophila larvae
ILP4 and InR regulate Paclitaxel-induced hypersensitivity differently in Drosophila larvae
Abstract Paclitaxel (PTX), a chemotherapeutic that stabilizes microtubules, induces nociceptive hypersensitivity and sensory neuron damage in humans, mice, and flies. T...
Hair Loss Associated with Sertraline: A Case Report
Hair Loss Associated with Sertraline: A Case Report
Sertraline is classified as a selective serotonin reuptake inhibitor (SSRI) that is extensively employed in the management of a range of psychiatric conditions, encompassing major ...
ASTM Symposium on the Recovery and Enumeration of Mycobacteria from the Metalworking Fluid Environment
ASTM Symposium on the Recovery and Enumeration of Mycobacteria from the Metalworking Fluid Environment
Abstract Since 1994, when the first documented hypersensitivity pneumonitis cluster was reported at a metalworking plant, there have been approximately 200 diagnosed...
Brentuximab-induced pneumonitis and organizing pneumonia: a case report with literiture review
Brentuximab-induced pneumonitis and organizing pneumonia: a case report with literiture review
Introduction and importance: Brentuximab vedotin (BV) is an anti-CD30 antibody approved for various cancers, including refractory Hodgkin lymphoma (HL), anaplastic larg...
The effect of sertraline-selenium combination on cardiac contractile strength
The effect of sertraline-selenium combination on cardiac contractile strength
Objectives: Individuals with myocardial infarction (MI) frequently exhibit a heightened prevalence of depression, which elevates the likelihood of negative cardiovascular outcomes...
Update on Drug-Induced Pneumonitis in Lung Cancer
Update on Drug-Induced Pneumonitis in Lung Cancer
AbstractDrug-induced pneumonitis is a significant and potentially life-threatening complication associated with multiple lung cancer therapies. As novel therapies are introduced an...

Back to Top